Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana (NYSE: HUM) signed a new joint venture agreement with BlackRock-managed funds and accounts covering nearly 150 CenterWell Senior Primary Care clinics. BlackRock will acquire WCAS’s equity stake, valued at approximately $2.8 billion, replacing the existing joint ventures. BlackRock will hold majority ownership, with CenterWell retaining minority ownership and managing all venture clinics.
Humana expects lower balance-sheet liabilities from removing existing arrangements requiring equity purchases, and a lower cost of capital. The venture expects to deploy additional capital over the next two years for operations, new clinics and acquisitions. CenterWell can elect to buy clinics beginning in 2028. Closing is expected in the fourth quarter of 2026, subject to state and federal regulatory approval and customary conditions. Humana expects no material impact on its 2026 adjusted earnings guidance.
Humana (NYSE: HUM) will release its third-quarter 2026 financial results and prepared management remarks on November 6, 2026. Results and remarks will be available at 6:00 a.m. Eastern time, followed by a live question-and-answer session at 8:00 a.m. to discuss quarterly results and 2026 earnings guidance. The webcast will be accessible through Humana’s Investor Relations page, with an archive available approximately two hours afterward.
Humana (HUM) announced improved 2027 CMS Star Ratings, with 95% of its Medicare Advantage members enrolled in plans rated 4.0 stars or above. Another reported measure shows 42% of members enrolled in 4.5-star plans. CMS evaluates plans annually on a five-star scale covering care quality, member experience and customer service.
Humana has six Medicare Advantage contracts rated 4.5 stars and 12 rated 4.0 stars for 2027, with 11 additional contracts rated 4.0 stars or above compared with the prior year. Its prescription drug plan contract earned 4.5 stars. Compared with the prior year, 663,000 more care opportunities were met and 534,000 additional members completed an annual preventive visit.
Humana (HUM) and the University of Louisville published an analysis estimating nearly $20 billion in Kentucky economic activity during 2025.
The analysis uses IMPLAN economic modeling and several years of company financial data. Approximately $6.4 billion in direct Kentucky output, combined with indirect and induced effects, produced an estimated $19.9 billion in total output. Humana’s approximately $952 million in direct Kentucky payroll generated an estimated $3.8 billion in total labor income. Statewide business activity and related effects generated an estimated $3.25 billion in local, state and federal taxes.
Humana (HUM) is offering 2027 Medicare Advantage plans with affordable monthly premiums and expanded coverage options for people with qualifying chronic conditions. Plans are available in approximately 2,600 counties across 45 states and Washington, D.C., reaching more than 80% of U.S. counties.
Chronic Condition Special Needs Plans, designed for people with qualifying chronic health conditions, expand into Pennsylvania, Utah and Wisconsin. Offerings include new $0 in-network routine lab services, continued $0 in-network primary care copays in eligible plans, and dental, vision and hearing benefits. Monthly premiums are $0 or low, and eligible plans retain $0 copays on hundreds of prescription medications.
Humana (HUM) reports new research linking CenterWell Specialty Pharmacy oncology care coordination services with improved outcomes and lower costs for cancer patients in Medicare Advantage with Part D coverage.
The retrospective observational study, published in Expert Review of Pharmacoeconomics & Outcomes Research, compared members receiving medication adherence care coordination from Humana’s CenterWell Specialty Pharmacy Oncology Center of Excellence with those who opted out or used other pharmacies. Statistical modeling found associations with an 11.7% reduction in hospitalizations, 2.7% fewer emergency department visits, and a 7.7% reduction in medical costs. These associations held across age, gender, and geography. The company notes that results show associations only, not causation, and may not generalize beyond the studied Medicare Part D population.
Humana (HUM) reported that its Humana Community Day 2026, held on August 26, mobilized more than 18,000 employees in 28 states and Puerto Rico to support community health through a nationwide day of service.
Now in its third year, the initiative involved 1,200+ nonprofit partners and, by the company’s count, positively impacted 2.25 million lives. Employees contributed 55,000+ volunteer hours, organized 750+ food drives and events, and helped pack, prepare or distribute 2.2 million meals. CenterWell’s annual food drive added participation from more than 9,500 employees, donating over 53,000 pounds of packaged food and $60,000, reaching more than 800,000 community members. Local efforts included over 1 million meals packed in Louisville and virtual volunteerism that produced more than 5,900 cards, videos and letters of encouragement.
Humana (HUM) reported peer-reviewed research linking integrated specialty pharmacy care to nearly six days faster access to specialty medications for Medicare Advantage beneficiaries.
The study of more than 23,000 Humana Medicare Advantage members using CenterWell Specialty Pharmacy found integrated pharmacy services were associated with about $106 lower annual out-of-pocket pharmacy costs versus non-integrated specialty pharmacies. A fully integrated model that also connects primary care and the health plan was associated with roughly $165 lower annual pharmacy costs.
Humana (HUM) has earned 2026 Great Place To Work Certification™ for the fifth consecutive year and again made the PEOPLE Companies That Care® list. These honors reflect a workplace culture focused on support, purpose and impact for employees, members and communities.
In the 2026 Great Place To Work survey, 79% of employees said Humana is a great place to work versus 57% at a typical U.S. company. Additional results show 90% feel welcome when they join, 86% feel good about Humana’s community contributions, and 84% believe people care about each other at the company. In 2025, more than 12,000 associates joined Community Day, supporting 600 nonprofits and impacting 1.6 million lives, while associates contributed over 321,000 volunteer hours and more than 20,000 employees participated in Network Resource Groups.
Humana (HUM) declared a quarterly cash dividend of $0.885 per share, approved by its Board of Directors. The dividend is payable on November 27, 2026 to stockholders of record as of the close of business on October 30, 2026.
The company describes itself as a U.S. healthcare provider serving Medicare, Medicaid, individual and family members, military personnel and communities through Humana insurance services and CenterWell healthcare services.